Exigencin mediates blood fibrinolysis. Delays and prevents blood clotting. May acts as blood thinner.
Prevents Vaso-occlusive crisis as seen in Stroke and Sickle cell disease
Upgregulation of UCP-1 in the white adipose tissue resulting in weight loss. Depletes stored fat. Promotes satiety, improves caloric utilisation and gut health. Mitigates hypercholestrolemia. Improves cardiovascular health.
Strongly activates TGR5. Weak GLP1 receptor agonism. Strongly inhibits DYRK1A. Hypoglycemic overall effect on prolonged usage.
